ר¼ÒºôÓõ½øÐдó¹æÄ£Ñо¿¸Ä±ä³¦µÀϸ¾ú¹¹³É£¬ÓпÉÄܼõÉÙ×Ô±ÕÖ¢Æ×ϵÕϰ£¨Autism Spectrum Disorder£¬ASD£©»¼ÕßÖ¢×´¡£Ä¿Ç°ÎªÖ¹£¬Ò½»¤ÈËԱͨ¹ý¿µ¸´
2017-06-21
Ȥζ°Ù¿Æ
vwinµÂÓ® >Ȥζ°Ù¿Æ >
2016×îÐÂSCIÓ°ÏìÒò×Ó£¨journal citation reports£¬JCR£©ÒÑÓÚ½üÆÚ¹«²¼ÁË£¬Ã¿ÄêµÄÄê¶ÈSCIÆÚ¿¯µÄ×îÐÂÓ°ÏìÒò×Ó»áÔÚÏÂÒ»Äê¶È³öÀ´¡£Òò´Ë½ñ
2017-06-19
Ȥζ°Ù¿Æ
À´×ÔÎ人´óѧÉú¿ÆÔº£¬ÖпÆÔºÉϺ£Éú»¯Óëϸ°ûËùµÄÑо¿ÈËÔ±·¢±íÁËÌâΪ¡°Cholesterol andfatty acids regulate cysteine ubi
2017-06-14
Ȥζ°Ù¿Æ
À´×Ô»ª¶«Àí¹¤´óѧ£¬Öйú¿ÆÑ§¼¼Êõ´óѧµÈ´¦µÄÑо¿ÈËÔ±·¢±íÁËÌâΪ¡°Genetically encoded fluorescent sensors reveal dyn
2017-06-07
Ȥζ°Ù¿Æ
ÉúÎïͨ±¨µÀ À´×Ô¸´µ©´óѧÄÔ¿ÆÑ§Ñо¿Ôº¡¢Ò½Ñ§Éñ¾ÉúÎïѧ¹ú¼ÒÖØµãʵÑéÊÒµÄÑо¿ÈËÔ±·¢±íÁËÌâΪ¡°Drug-seeking motivation level in mal
2017-06-06
Ȥζ°Ù¿Æ
½áÖ±³¦°©ÊÇÊÀ½ç·¶Î§µ¼ÖÂËÀÍöÈËÊý×î¶àµÄ¶ñÐÔÖ×ÁöÖ®Ò»£¬ÎÒ¹ú½áÖ±³¦°©µÄ·¢²¡ÂÊÖð½¥Éý¸ß£¬·¢²¡ÈËÊýÒѾ³¬¹ýÃÀ¹ú£¬Òò´Ë½áÖ±³¦°©¶ÔÎÒ¹úÈ˿ڽ¡¿µµÄΣº¦Ê®·ÖÑÏÖØ¡£ÍíÆÚ½áÖ±³¦°©µÄÊÖ
2017-05-25
Ȥζ°Ù¿Æ
À´×ÔÇ廪´óѧҽѧԺµÄ³Ì¹¦Ñо¿×éÓëÃÀ¹úµÂ¿ËÈøË¹´óѧҽѧ²¿£¨UTMB£©Ê·ÅåÓ£¨pei-Yong Shi£©½ÌÊÚÑо¿×éºÏ×÷ÔÚNatureÔÓÖ¾ÉÏ·¢ÎÄ£¬Ö¸³ö½ø»¯µ¼ÖÂÁËÕ¯¿¨²¡
2017-05-23
Ȥζ°Ù¿Æ
¹¬¾±°©¼ò½é¹¬¾±°©ÊÇÅ®ÐÔ×î³£¼ûµÄ¶ñÐÔÖ×ÁöÖ®Ò»£¬ÆäËÀÍöÂʽö´ÎÓÚÈéÏÙ°©¡£½üÄêÀ´£¬¹¬¾±°©µÄ·¢Õ¹Ç÷ÊÆÖð½¥Æ«ÏòÄêÇữÇÒ³ÊÖðÄêÉÏÉýÏÖÏó¡£ÈËÈéÍ·Áö²¡¶¾( HpV)¸ÐȾÓ빬¾±°©ÓÐ
2017-05-17
Ȥζ°Ù¿Æ
ÈÕǰ£¬ÉϺ£½»Í¨´óѧҽѧԺҩÀíѧÓ뻯ѧÉúÎïѧϵ¸ßСÁáÑо¿Ô±¿ÎÌâ×éÔÚ¡¶Nature¡·×Ó¿¯¡¶Nature Communications¡·ÔÚÏß·¢±íÁËÌâΪ¡°Lipopro
2017-05-16
Ȥζ°Ù¿Æ
5ÔÂ3ÈÕ£¬µÚ¶þ¾üÒ½´óѧÀ׳¤º£½ÌÊںͺúÊʲ©Ê¿¿ÎÌâ×éÐû²¼£¬ËûÃÇÉè¼Æ³öÒ»ÖÖÐÂÐÍÖ×Áö°ÐÏòÖÎÁÆ·½°¸£¬²¢×ÔÖ÷ÖÆ±¸ÁËÒ»ÖÖÐÂÐÍ¿¹ÌåÒ©ÎÄÜÓÐЧ×èÖ¹Ö×ÁöÉú³¤¡£¾Ý½éÉÜ£¬ÔÚÖ×ÁöµÄ·Ö×Ó
2017-05-05
Ȥζ°Ù¿Æ
À´×ÔÏã¸ÛÀí¹¤´óѧµÄÑо¿ÈËÔ±±¨µÀÁËÒ»ÖÖ¾ßÓÐË«ÖØ¹¦Ð§µÄ¡°Æ½°ÌÌù¡±¼¼Êõ£¬ÕâÖÖÖÎÁÆ·½·¨ÄÜÖÎÁÆÒòÉÕÉË¡¢ÊÖÊõ¡¢´´É˶øÐγɵÄÔöÉúÐ԰̺ۣ¬¼æ¾ßÓд«Í³Ñ¹Á¦µæ¼°¹èÄý½ºÌùµÄÓŵ㡣ͬʱ
2017-04-28
Ȥζ°Ù¿Æ
¡¡Öйú¿ÆÑ§Ôº±±¾©»ùÒò×éÑо¿Ëù¾«×¼»ùÒò×éÒ½Ñ§ÖØµãʵÑéÊÒ¼°ÒÅ´«Óë·¢ÓýÐͬ´´ÐÂÖÐÐÄÑîÔ˹ðÑо¿×éºÍÖ£ÖÝ´óѧµÚÒ»¸½ÊôÒ½ÔºÉúÖ³ÓëÒÅ´«×¨¿ÆÒ½ÔºËïÓ¨è±Ñо¿×é¡¢Öйú¿ÆÑ§ÔºÉú̬»·¾³
2017-04-25
Ȥζ°Ù¿Æ
¹ã¶«¹¤Òµ´óѧÕÔ×Ó½¨½ÌÊÚÓëÄϾ©Ò½¿Æ´óѧÀîÏþêØ²©Ê¿ºÏ×÷Ñо¿£¬½ÒʾÁËOmega-3¶à²»±¥ºÍÖ¬·¾ËáÔÚ1ÐÍÌÇÄò²¡ÖеĹؼüµ÷½Ú×÷Ó㬲¢²ûÃ÷ÁËÆä×÷ÓõķÖ×Ó»úÖÆ¡£ÕâÒ»Ñо¿½á¹ûÒÔ
2017-04-18
Ȥζ°Ù¿Æ
Ó¢¹ú²é¶û·ÒÌØ-Ê¥¼Ö¶û˹-2017Äê4ÔÂ11ÈÕ¡ª¡ªGEÒ½ÁÆÐû²¼³É¹¦²¢¹º AsymptoteÓÐÏÞ¹«Ë¾¡ª¡ªÒ»¼ÒΪ»·¾³Ãô¸ÐµÄϸ°ûÖÎÁÆÌṩµÍÎÂÁ´¼¼ÊõµÄרҵ¹«Ë¾¡£Asymp
2017-04-17
Ȥζ°Ù¿Æ
À´×ÔÖпÆÔºÉϺ£ÉúÃü¿ÆÑ§Ñо¿ÔºÖ²ÎïÄæ¾³ÉúÎïѧÑо¿ÖÐÐÄÐÜÑÓÑо¿×éºÍÐìͨ´ïÑо¿×éºÏ×÷Íê³ÉµÄÌâΪ¡°Differential TOR activation and cel
2017-04-11
Ȥζ°Ù¿Æ
2017Äê3ÔÂ23ÈÕ£¬Õã½´óѧÍô·½ì¿ÊµÑéÊÒÔÚ¹ú¼ÊȨÍþѧÊõÆÚ¿¯Current Biology£¨¡¶Cell¡·×Ó¿¯£¬ÎåÄêÆ½¾ùÓ°ÏìÒò×Ó9 733£©ÒÔ¡°Article£¨³¤
2017-04-06
Ȥζ°Ù¿Æ
À´×ÔÇ廪´óѧÉúÃü¿ÆÑ§Ñ§Ôº£¬IDG McGovernÄÔ¿ÆÑ§Ñо¿ËùµÈ´¦µÄÑо¿ÈËÔ±·¢±íÁËÌâΪ¡°Activity-induced histone modificatio
2017-03-31
Ȥζ°Ù¿Æ
ÿÄêpacbio¹«Ë¾·¢Æð¡°SMRT Grant program¡±½ñÄ꣬еÄÒ»ÆÚ¼ÌÐø½øÐУ¬ÓëÒÔÍù²»Í¬µÄÊÇ£¬Õâ´ÎµÄÏîÄ¿½«ÔÚ×îеÄSequelϵͳÉϽøÐС£´Ë´Î»î¶¯µÄÄ¿
2017-03-28
Ȥζ°Ù¿Æ
½üÈÕº£ÄÏ´óѧÈÈ´øÅ©ÁÖѧԺº£ÄÏÊ¡ÈÈ´øÉúÎï×ÊÔ´¿É³ÖÐøÀûÓÃÖØµãʵÑéÊÒÂÞÀö¾ê½ÌÊÚ¿ÎÌâ×éÓëÁõ½øÆ½½ÌÊÚ¿ÎÌâ×éºÏ×÷£¬½¨Á¢ÁËÒ»ÖÖ³ÉÊì¸ßЧµÄľÊíÒ¶ÈâÔÉúÖÊÌå˲ʱ±í´ïÌåϵ¡£ÕâÒ»Ñо¿
2017-03-20
Ȥζ°Ù¿Æ
±±¾©´óѧÉúÃü¿ÆÑ§Ñ§ÔºµÄ½¯Õù·²Ñо¿×é·¢ÏÖÑ×ÐÔСÌåÄܸºµ÷¿ØIÐ͸ÉÈÅËØÍ¨Â·£¬Ê״νÒʾcGASµ°°×N¶ËÐòÁÐÔÚʶ±ðϸ°ûÖÊDNA²¢»î»¯ÌìÈ»ÃâÒßÖз¢»ÓÖØÒªµÄÉúÀí¹¦ÄÜ£¬¸Ä±äÁËÈË
2017-03-16
Ȥζ°Ù¿Æ